US Patent Issued to Millennium Pharmaceuticals on Feb. 3 for "Anti-ADGRE2 antibodies and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,178, issued on Feb. 3, was assigned to Millennium Pharmaceuticals Inc. (Cambridge, Mass.).

"Anti-ADGRE2 antibodies and uses thereof" was invented by Antara Banerjee (Cambridge, Mass.), Xingyue He (Cambridge, Mass.) and Shawn Jennings (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies, fragments thereof and fusion proteins that specifically bind to ADGRE2, are described, as well as methods of making and using such antibodies. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various autoimmune diseases and cancers, including, for example, acute myeloid leukemia."

The patent w...